Literature DB >> 20169374

Peptide-based molecular beacons for cancer imaging and therapy.

Tracy W B Liu1, Juan Chen, Gang Zheng.   

Abstract

Peptide-based molecular beacons are Förster resonance energy transfer-based target-activatable probes. They offer control of fluorescence emission in response to specific cancer targets and thus are useful tools for in vivo cancer imaging. With our increasing knowledge about human genome in health and disease, peptide-based "smart" probes are continually developed for in vivo optical imaging of specific molecular targets, biological pathways and cancer progression and diagnosis. A class of fluorescent photosensitizers further extends the application of peptide beacons to cancer therapeutics. This review highlights the applications of peptide beacons in cancer imaging, the simultaneous treatment and response monitoring and smart therapeutics with a focus on recent improvements in the design of these probes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20169374     DOI: 10.1007/s00726-010-0499-1

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  11 in total

1.  Topical MMP beacon enabled fluorescence-guided resection of oral carcinoma.

Authors:  Laura Burgess; Juan Chen; Nikolaus E Wolter; Brian Wilson; Gang Zheng
Journal:  Biomed Opt Express       Date:  2016-02-29       Impact factor: 3.732

Review 2.  Trends in fluorescence image-guided surgery for gliomas.

Authors:  Jonathan T C Liu; Daphne Meza; Nader Sanai
Journal:  Neurosurgery       Date:  2014-07       Impact factor: 4.654

3.  Protein and peptide probes for molecular imaging.

Authors:  Xiaoyuan Chen
Journal:  Amino Acids       Date:  2011-11       Impact factor: 3.520

4.  Application of High-Throughput Competition Experiments in the Development of Aspartate-Directed Site-Selective Modification of Tyrosine Residues in Peptides.

Authors:  Alex J Chinn; Jaeyeon Hwang; Byoungmoo Kim; Craig A Parish; Shane W Krska; Scott J Miller
Journal:  J Org Chem       Date:  2020-07-02       Impact factor: 4.354

5.  Nanoparticle-based theragnostics: Integrating diagnostic and therapeutic potentials in nanomedicine.

Authors:  Chen Fang; Miqin Zhang
Journal:  J Control Release       Date:  2010-05-19       Impact factor: 9.776

6.  Multimodal bacteriochlorophyll theranostic agent.

Authors:  Tracy W B Liu; Juan Chen; Laura Burgess; Weiguo Cao; Jiyun Shi; Brian C Wilson; Gang Zheng
Journal:  Theranostics       Date:  2011-08-23       Impact factor: 11.556

7.  Transforming a Targeted Porphyrin Theranostic Agent into a PET Imaging Probe for Cancer.

Authors:  Jiyun Shi; Tracy W B Liu; Juan Chen; David Green; David Jaffray; Brian C Wilson; Fan Wang; Gang Zheng
Journal:  Theranostics       Date:  2011-09-15       Impact factor: 11.556

Review 8.  Intraoperative Fluorescence Imaging for Personalized Brain Tumor Resection: Current State and Future Directions.

Authors:  Evgenii Belykh; Nikolay L Martirosyan; Kaan Yagmurlu; Eric J Miller; Jennifer M Eschbacher; Mohammadhassan Izadyyazdanabadi; Liudmila A Bardonova; Vadim A Byvaltsev; Peter Nakaji; Mark C Preul
Journal:  Front Surg       Date:  2016-10-17

Review 9.  Protease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging.

Authors:  Caleb F Anderson; Honggang Cui
Journal:  Ind Eng Chem Res       Date:  2017-04-24       Impact factor: 3.720

Review 10.  Controllable Photodynamic Therapy Implemented by Regulating Singlet Oxygen Efficiency.

Authors:  Wenting Wu; Xiaodong Shao; Jianzhang Zhao; Mingbo Wu
Journal:  Adv Sci (Weinh)       Date:  2017-06-23       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.